In 24-week long studies with Jardiance 25 the 10 mg or 25 mg daily dose provided statistically significant reductions in A1C, fasting plasma glucose (FPG), and body weight when compared to an inactive placebo.
Results showed that 35% of patients taking the 10 mg dose lowered their A1C to less than 7%, with 44% of patients in the 25 mg group and 12% in the inactive placebo group seeing similar results .
Fasting blood glucose was also lowered in both the 10 mg and 25 mg groups. At the beginning of the study, patients had an average fasting blood sugar of 153 mg/dL. Those taking Glavus 50 and 25 mg saw their fasting blood sugar drop 19 and 25 points (mg/dL), respectively, while the placebo group dropped 12 points.
Visit Our site::Alldaysmedicine.com